oppalerts.com →
IVF Reproductive Medicine

Older Hopeful Parent

Knowledge Graph Entities
Dominant · SE Outbound Links ρ=0.458

AI recommendation signal analysis across 325 domains for the Older Hopeful Parent persona in IVF Reproductive Medicine.

325Domains Tracked
5.7MReddit Posts
4,350Wikipedia Articles
747KOpen Web Matches
Older Hopeful Parent_persona.report
EntityScore
Fertility and Sterility
86.1
Prelude Fertility
68.9
Pacific Fertility Center Los Angeles (PFCLA)
68.9
Mayo Clinic
60.0
LoopNet
60.0
Want a custom AI visibility audit for IVF Reproductive Medicine?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch
About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.
Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches Older Hopeful Parent. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

22K
Entities With Topic Matches
4,786
Entities Mentioning Brands
23K
Topic Phrase Matches
5,111
Brand Mentions
Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

10 of 25 top domains for Older Hopeful Parent have a knowledge-graph entity.

DomainKnowledge Graph EntityWikidata ID
ccrmivf.comColorado Center for Reproductive MedicineQ30281877
rmanetwork.comNot in the knowledge graph-
shadygrovefertility.comShady Grove Fertility CenterQ30281964
sart.orgNot in the knowledge graph-
reproductivefacts.orgNot in the knowledge graph-
springfertility.comNot in the knowledge graph-
cnyfertility.comNot in the knowledge graph-
fertilityiq.comNot in the knowledge graph-
nyulangone.orgNYU Langone HealthQ6956114
weillcornell.orgWeill Cornell MedicineQ3567094
rmany.comReproductive Medicine Associates of New YorkQ30274383
columbiafertility.orgNot in the knowledge graph-
extendfertility.comNot in the knowledge graph-
sartcorsonline.comNot in the knowledge graph-
resolve.orgNot in the knowledge graph-
centerforhumanreprod.comCenter for Human ReproductionQ30281404
columbiadoctors.orgNot in the knowledge graph-
scrcivf.comSouthern California Reproductive CenterQ107518945
brighamandwomens.orgBrigham and Women's HospitalQ2900977
reproductivepartners.comNot in the knowledge graph-
hrcfertility.comNot in the knowledge graph-
crmny.comNot in the knowledge graph-
fertilitycenter.comNot in the knowledge graph-
asrm.orgAmerican Society for Reproductive MedicineQ466817
bostonivf.comBoston IVFQ30269486
Wikidata

Top knowledge-graph entities

The entity records where Older Hopeful Parent's brands and topics appear. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.


EntityBlendedBrand MentionsTopic Matches
Fertility and Sterility86.133
Prelude Fertility68.931
Pacific Fertility Center Los Angeles (PFCLA)68.931
Mayo Clinic60.040
LoopNet60.040
Human Resource Management Review60.040
Midwest Fertility Specialists58.221
Colorado Center for Reproductive Medicine58.221
Sher Fertility58.221
National Institute for Occupational Safety and Health51.730
Brain and Language51.730
Virology51.730
Applied Mathematics and Computation51.730
Advances in Virus Research51.730
Advances in Parasitology51.730
Vital and health statistics. Series 21, Data on natality, marriage, and divorce51.730
Vital and health statistics. Series 5, Comparative international vital and health statistics reports51.730
Pacific Fertility Center51.730
Chronic Diseases and Translational Medicine51.730
World Journal of Otorhinolaryngology-Head and Neck Surgery51.730
Office of Readiness and Response51.730
American Society for Reproductive Medicine43.111
Reproductive Medicine Associates of New York43.111
Reproductive Medicine Associates of New Jersey43.111
Reproductive Medicine Institute43.111
Wave Motion41.020
Ultrasonics Sonochemistry41.020
Massachusetts General Hospital41.020
Nucleic Acids Research41.020
Q22988341.020
Clinical Genitourinary Cancer41.020
Journal of Economic Theory41.020
Blood41.020
Tetrahedron Letters41.020
Nuclear Physics41.020
Trends in Cell Biology41.020
Intelligence41.020
Journal of Operations Management41.020
Brachytherapy41.020
Mechanisms of Ageing and Development41.020
Trends in Cardiovascular Medicine41.020
Seminars in Cancer Biology41.020
Journal of Crystal Growth41.020
Field Crops Research41.020
Cardiovascular Pathology41.020
Biophysical Journal41.020
Physica C41.020
Computer Communications41.020
Robotics and Autonomous Systems41.020
Marine Micropaleontology41.020
Comptes Rendus. Biologies41.020
Mathematical Biosciences41.020
International Journal of Medical Informatics41.020
Postharvest Biology and Technology41.020
Nuclear Physics A41.020
Toxicological Sciences41.020
Toxicology and Applied Pharmacology41.020
Advances in Agronomy41.020
Cancer Detection and Prevention41.020
Cancer Radiothérapie41.020
Epi Info41.020
Microelectronic Engineering41.020
Optical Switching and Networking41.020
Journal of Communication Disorders41.020
Agricultural Systems41.020
Applied Catalysis A: General41.020
Applied Clay Science41.020
International Review of Cytology41.020
International Journal of Obstetric Anesthesia41.020
Nuclear Physics B41.020
Annales pharmaceutiques françaises41.020
Coordination Chemistry Reviews41.020
Food Chemistry41.020
Journal of Molecular Structure41.020
Journal of the American Society for Mass Spectrometry41.020
Electrochemistry Communications41.020
Fuel Processing Technology41.020
Advances in Cancer Research41.020
Journal of Fluorine Chemistry41.020
Journal of Pharmaceutical Sciences41.020
Microporous and Mesoporous Materials41.020
Progress in Solid State Chemistry41.020
Radiation Physics and Chemistry41.020
Rusk Institute of Rehabilitation Medicine41.020
Vibrational Spectroscopy41.020
Weill Cornell Medicine41.020
Physiology & Behavior41.020
Vacuum41.020
Cleveland Clinic41.020
Computers and Electronics in Agriculture41.020
Advances in Mathematics41.020
American Journal of Preventive Medicine41.020
American Journal of Translational Research41.020
Biomedical Optics Express41.020
Brain Research41.020
China Economic Review41.020
Cultural Diversity and Ethnic Minority Psychology41.020
dbSNP41.020
Early Childhood Research Quarterly41.020
Experimental Hematology41.020
Geochimica et Cosmochimica Acta41.020
Journal of Memory and Language41.020
Journal of Second Language Writing41.020
Journal of Sound and Vibration41.020
Journal of the Academy of Nutrition and Dietetics41.020
Laboratory Investigation41.020
Learning and Individual Differences41.020
Magnetic Resonance Imaging41.020
Museum Management and Curatorship41.020
Personality and Individual Differences41.020
Preventing Chronic Disease41.020
Quaternary Research41.020
Western Journal of Medicine41.020
Transplantation Proceedings41.020
Trends in Amplification41.020
Ulster Medical Journal41.020
The AAPS Journal41.020
Finite Elements in Analysis and Design41.020
Linear Algebra and its Applications41.020
Annales de l'Institut Henri Poincare C41.020
Applied Mathematics Letters41.020
Applied Numerical Mathematics41.020
Current Opinion in Genetics & Development41.020
Journal of Fluency Disorders41.020
Nonlinear Analysis41.020
Nuclear Instruments & Methods in Physics Research B41.020
Rice41.020
Seminars in Cell & Developmental Biology41.020
Systems & Control Letters41.020
NeuroToxicology41.020
Differential Geometry and its Applications41.020
Journal of Combinatorial Theory, Series B41.020
Journal of Mathematical Analysis and Applications41.020
Journal of Web Semantics41.020
Pathophysiology41.020
BJOG: an International Journal of Obstetrics and Gynaecology41.020
Archives of Gerontology and Geriatrics41.020
Cryptogamie Bryologie41.020
Advances in Marine Biology41.020
BBA: Molecular Basis of Disease41.020
Global Finance Journal41.020
Advances in Carbohydrate Chemistry and Biochemistry41.020
AAPS PharmSciTech41.020
Brain and Development41.020
Cryptogamie Algologie41.020
Aggression and Violent Behavior41.020
Pediatric Neurology41.020
General Hospital Psychiatry41.020
Comparative Immunology, Microbiology & Infectious Diseases41.020
International Journal of Mental Health Systems41.020
Advances in Applied Microbiology41.020
Optometry - Journal of the American Optometric Association41.020
Journal of Policy Modeling41.020
Best Practice and Research: Clinical Gastroenterology41.020
International Journal of Law and Psychiatry41.020
Prostaglandins and Other Lipid Mediators41.020
Building and Environment41.020
Industrial Marketing Management41.020
Meat Science41.020
Research in Organizational Behavior41.020
Fish and Shellfish Immunology41.020
Journal of Immunological Methods41.020
Human Pathology41.020
Comparative Biochemistry and Physiology. Part A: Molecular and Integrative Physiology41.020
The History of the Family41.020
Journal of Environmental Management41.020
Insight41.020
Business Horizons41.020
Computers in Human Behavior41.020
Government Information Quarterly41.020
Linguistics and Education41.020
Cryptogamie Mycologie41.020
Behaviour Research and Therapy41.020
Advances in Botanical Research41.020
Journal of Urban Health41.020
Comptes Rendus. Géoscience41.020
Neural Development41.020
Socio-Economic Planning Sciences41.020
Organizational Dynamics41.020
The American Journal of Surgery41.020
Clinical Neurophysiology41.020
Ocean Engineering41.020
International Review of Law and Economics41.020
Nuclear Physics B - Proceedings Supplements41.020
Revue Europeene de Psychologie Appliquee41.020
Computers & Graphics41.020
Journal of African Earth Sciences41.020
Journal of the Society of Laparoendoscopic Surgeons41.020
Annual Reports in Medicinal Chemistry41.020
Comparative Biochemistry and Physiology. Part D: Genomics and Proteomics41.020
European Journal of Mechanics A - Solids41.020
Computers and Composition41.020
Review of Financial Economics41.020
Maturitas41.020
Financial Services Review41.020
Mechanics Research Communications41.020
Journal of Cultural Heritage41.020
Clinical Imaging41.020
Journal of Environmental Sciences41.020
Journal of Clinical Lipidology41.020
Journal of Orthopaedics, Trauma and Rehabilitation41.020
Ticks and Tick-borne Diseases41.020
The Electricity Journal41.020
Social Science Research41.020
Archives of Cardiovascular Diseases Supplements41.020
National Survey of Family Growth41.020
National Vital Statistics System41.020
NIOSH Power Tools Database41.020
UCLA Health System41.020
Q2064174241.020
Advances in Nutrition41.020
Morbidity and Mortality Weekly Report: Recommendations and Reports41.020
Filtration & Separation41.020
Fundamental and Applied Toxicology41.020
Journal of the Less Common Metals41.020
Scripta Metallurgica41.020
Diseases of the chest41.020
Chemical health & safety American Chemical Society, Division of Chemical Health and Safety41.020
Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo41.020
Behavioral Biology41.020
The Journal of clinical and aesthetic dermatology41.020
Alcohol research : current reviews41.020
Cell Biology International Reports41.020
Vital & health statistics. Series 3, Analytical and epidemiological studies41.020
Dermato-endocrinology41.020
British Heart Journal41.020
The western journal of emergency medicine41.020
Prostate international41.020
Psychiatry41.020
Mycobiology41.020
The Lancet Psychiatry41.020
Advances in food research41.020
Science in China. Series B, Chemistry, life sciences & earth sciences41.020
Genetic analysis, techniques and applications41.020
Journal of the American Pharmaceutical Association41.020
Vital and health statistics. Series 3, Analytical studies41.020
Vital and health statistics. Ser. 4, Documents and committee reports41.020
Vital and health statistics. Series 13, Data from the National Health Survey41.020
Journal of epilepsy41.020
Ethology and sociobiology41.020
Aging trends (Hyattsville, Md.)41.020
Clinical microbiology newsletter41.020
NCHS data brief41.020
Journal of Verbal Learning and Verbal Behavior41.020
Paediatrics and Child Health41.020
The Lancet: Diabetes & Endocrinology41.020
Avian Research41.020
Alzheimer's & dementia (Amsterdam, Netherlands)41.020
Cell Chemical Biology41.020
MMWR supplements41.020
Clinical neurophysiology practice41.020
Information and control41.020
Studies in Logic and the Foundations of Mathematics41.020
Computing systems in engineering : an international journal41.020
National Center for Emerging and Zoonotic Infectious Diseases41.020
Division of Parasitic Diseases and Malaria41.020
San Diego Fertility Center41.020
Chronic Disease Prevention and Health Promotion41.020
Shady Grove Fertility Center41.020
Cooper Health System41.020
The Journal of Finance and Data Science41.020
CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows41.020
Fertility Centers of Illinois41.020
New Hope Fertility Center41.020
Johns Hopkins Medicine41.020
Journal of Urban Management41.020
Journal of Asian Ceramic Societies41.020
Climate Risk Management41.020
Information Processing in Agriculture41.020
Advances in Inorganic Chemistry and Radiochemistry41.020
Fish Physiology41.020
Computer Vision, Graphics, and Image Processing41.020
Network Security41.020
Inorganic and Nuclear Chemistry Letters41.020
Inorganica Chimica Acta Reviews41.020
Information Storage and Retrieval41.020
bidirectional encoder representations from transformers41.020
Biometric Technology Today41.020
Membrane Technology41.020
Filtration Industry Analyst41.020
Fuel Cells Bulletin41.020
Journal of Patient Safety & Infection Control41.020
Pump Industry Analyst41.020
Space Research Today41.020
World Pumps41.020
Christopher R. Conley41.020
Blastocyst culture and transfer in clinical-assisted reproduction40.004
Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion40.004
Blastocyst culture and transfer in clinical-assisted reproduction40.004
Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion40.004
assisted reproductive technology34.503
fertility clinic34.503
The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women34.503
Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone34.503
A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey34.503
Age-Related Normogram for Ovarian Antral Follicle Count in Women with Polycystic Ovary Syndrome and Comparison with Age Matched Controls Using Magnetic Resonance Imaging34.503
Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve34.503
Preimplantation genetic testing: a Practice Committee opinion34.503
Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction34.503
Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone34.503
The correlation of the antral follicle count and Serum anti-mullerian hormone34.503
Elective single-embryo transfer34.503
Shifting Paradigms in Diminished Ovarian Reserve and Advanced Reproductive Age in Assisted Reproduction: Customization Instead of Conformity34.503
Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices34.503
Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down's syndrome.34.503
Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 201234.503
Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization34.503
Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable?34.503
Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles34.503
Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?34.503
Effect of premature serum progesterone rise on embryo transfer outcomes and the role of blastocyst culture and transfer in assisted reproductive technology cycles with premature progesterone rise34.503
Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure34.503
Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer34.503
Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle34.503
A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age34.503
Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve34.503
Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study34.503
Anti-Mullerian Hormone (AMH) and Antral Follicle Count as Markers of Ovarian Reserve- Prospective Followup of Young Cancer Patients34.503
Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines34.503
Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women of more advanced reproductive age with elevated serum follicle stimulating hormone (FSH) levels34.503
Preimplantation genetic testing: a Practice Committee opinion34.503
Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer34.503
Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers34.503
The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion34.503
Can delivery mode influence future ovarian reserve? Anti-Mullerian hormone levels and antral follicle count following cesarean section: a prospective cohort study34.503
A 5-year analysis of demographics, cycle characteristics and reproductive outcomes of 907 egg freezing cycles in patients with diminished ovarian reserve and age-related fertility decline34.503
Does embryo biopsy, independent of vitrification, impact perinatal outcomes? An analysis of perinatal outcomes following preimplantation genetic testing biopsy in fresh and frozen embryo transfer cycles34.503
Anti-mullerian hormone level as a predictor of ovarian reserve in patients seeking fertility preservation versus infertility treatment34.503
Embryo biopsy does not affect the rate of multiples after single embryo transfer (SET): a review of the society for assisted reproductive technology (SART) reported outcomes34.503
Antral Follicle Count versus Basal Follicle Stimulating Hormone as Predictors of Ovarian Response in Women Undergoing Superovulation with Long Protocol for Assisted Reproduction34.503
GYN-FIV a.s.34.503
egg donation27.302
Journal of Assisted Reproduction and Genetics27.302
Reproductive Medicine and Biology27.302
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)27.302
Post-embryo transfer interventions for assisted reproduction technology cycles27.302
Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology27.302
Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology27.302
Soft versus firm embryo transfer catheters for assisted reproductive technology27.302
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles27.302
Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility27.302
Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology27.302
A Review of The Society for Assisted Reproductive Technology Embryo Grading System and Proposed Modification27.302
Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers27.302
<i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology —27.302
Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents27.302
What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?27.302
Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic27.302
Urinary phthalate metabolites and ovarian reserve among women seeking infertility care27.302
Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation andin vitrofertilization success? A prospective data analysis27.302
Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion27.302
Pregnancy outcomes after assisted reproductive technology27.302
Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy27.302
Chromosomal abnormalities in miscarriages after different assisted reproduction procedures.27.302
Fertility clinic, egg donation agency, and sperm bank policies27.302
The status of assisted reproductive technology in Korea in 201227.302
Live birth in a 46 year old using autologous oocytes cryopreserved for a duration of 3 years: a case report documenting fertility preservation at an advanced reproductive age27.302
A successful pregnancy following 'double rescue' egg retrieval in a woman with Natural cycle IVF27.302
The incidence of monozygotic twinning in assisted reproductive technology: Analysis based on results from the 2010 Japanese ART national registry27.302
Antral follicle count in normal (fertility-proven) and infertile Indian women27.302
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.27.302
RETIRED: Advanced Reproductive Age and Fertility27.302
How the FMR1 gene became relevant to female fertility and reproductive medicine27.302
Age = egg quality, FSH level = egg quantity27.302
Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH27.302
Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011.27.302
Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database27.302
Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study.27.302
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial.27.302
Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study27.302
Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment27.302
Anti-Mullerian Hormone: A Marker of Ovarian Reserve and its Association with Polycystic Ovarian Syndrome27.302
Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view27.302
The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort study27.302
Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion27.302
Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.27.302
Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway27.302
Chronological age vs biological age: an age-related normogram for antral follicle count, FSH and anti-Mullerian hormone.27.302
A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti27.302
Fertility treatment when the prognosis is very poor or futile27.302
Access to fertility treatment by gays, lesbians, and unmarried persons27.302
Risk of Chromosomal Abnormalities in Early Spontaneous Abortion after Assisted Reproductive Technology: A Meta-Analysis27.302
Ongoing Pregnancy Rates in Women with Low and Extremely Low AMH Levels. A Multivariate Analysis of 769 Cycles27.302
Evidence to Incorporate Inclusive Reproductive Health Measures in Guidelines for Childhood and Adolescent Cancer Survivors27.302
Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women27.302
A legal-ethical analysis of reproductive endocrinologists' right to refuse ovulation induction to patients with diminished ovarian reserve27.302
The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility27.302
Optimal timing for elective egg freezing27.302
What is the most relevant standard of success in assisted reproduction?: challenges in measuring and reporting success rates for assisted reproductive technology treatments: what is optimal?27.302
Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function27.302
Oocyte retrieval at 140-mmHg negative aspiration pressure: A promising alternative to flushing and aspiration in assisted reproduction in women with low ovarian reserve27.302
What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality27.302
Antiphospholipid antibodies do not affect IVF success27.302
Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes27.302
Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study27.302
Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation27.302
Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System27.302
Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity27.302
Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.27.302
Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention27.302
Use of anti-mullerian hormone for testing ovarian reserve: a survey of 796 infertility clinics worldwide27.302
Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey27.302
Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis27.302
The practical implications of a raised serum FSH and age on the risk of IVF treatment cancellation due to a poor ovarian response27.302
Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.27.302
A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment27.302
Elective single-embryo transfer improves cumulative pregnancy outcome in young patients but not in women of advanced reproductive age27.302
Day 3 embryo transfer may have better pregnancy outcomes in younger than 35-year-old patients with poor ovarian response27.302
Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization27.302
Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons27.302
Oncofertility: a grand collaboration between reproductive medicine and oncology27.302
Embryo transfer in days 2 to 4 following intracytoplasmic sperm injection: a prospective cohort study27.302
Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates27.302
Genetic considerations related to intracytoplasmic sperm injection (ICSI).27.302
Guidelines for reducing the risk of viral transmission during fertility treatment27.302
Round spermatid nucleus injection (ROSNI).27.302
Anti-phospholipid antibodies do not affect IVF success27.302
Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation.27.302
The role of fertility preservation in patients with endometriosis27.302
Treatment strategies in assisted reproduction for women of advanced maternal age.27.302
Current status of assisted reproductive technology in Korea, 201127.302
On the Morphology of the Human Sertoli Cells under Normal Conditions and in Patients with Impaired Fertility*27.302
Antral follicle count determines poor ovarian response better than anti-müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles27.302
The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET).27.302
Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies27.302
Use of letrozole in assisted reproduction: a systematic review and meta-analysis.27.302
Post-thaw Embryo Transfer Cycles as the Future Hope for Boosting IVF Success Rates27.302
Maternal age-specific rates of fetal chromosomal abnormalities in Korean pregnant women of advanced maternal age27.302
The importance of rapid aneuploidy screening and prenatal diagnosis in the detection of numerical chromosomal abnormalities27.302
Determining an anti-mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve27.302
Assisted reproduction and fertility preservation techniques in cancer patients27.302
Optimizing natural fertility27.302
Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles27.302
Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies27.302
Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut27.302
Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction27.302
Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches27.302
Age-specific nomograms for follicle stimulating hormone and anti-Mullerian hormone: A pilot study in Ile-Ife, Nigeria27.302
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).27.302
Anti-mullerian hormone as a predictor of ovarian reserve and ovarian response in IVF women from Gaza strip27.302
Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location27.302
Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms27.302
Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review27.302
Anti-Mullerian Hormone: A New Marker of Ovarian Function27.302
Prevalence of chromosomal abnormalities and timing of karyotype analysis in patients with recurrent implantation failure (RIF) following assisted reproduction27.302
Human blastocyst culture in IVF: current laboratory applications in reproductive medicine practice27.302
The promise of in vitro maturation in assisted reproduction and fertility preservation.27.302
What is the role of assisted reproduction technology in the management of age-related infertility?27.302
Pregnancy rates following frozen embryo transfer (ET) in women failing to conceive despite fresh ET in women using low dosage follicle stimulating hormone (FSH) protocol for follicular maturation of several eggs27.302
Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion27.302
In vitro maturation: a committee opinion27.302
Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?27.302
Comprehensive chromosome screening of trophectoderm with vitrification facilitates elective single-embryo transfer for infertile women with advanced maternal age.27.302
The wobbly evidence base of reproductive medicine27.302
Freezing the biological clock: a viable fertility preservation option for young Singapore women?27.302
Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients27.302
Misconduct in third-party assisted reproduction: a committee opinion27.302
VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer27.302
Female age-related fertility decline. Committee Opinion No. 589.27.302
Cryopreservation and delayed embryo transfer-assisted reproductive technology registry and reporting implications27.302
Role of assisted hatching in in vitro fertilization: a guideline27.302
Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion27.302
The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis.27.302
AMH: An ovarian reserve biomarker in assisted reproduction.27.302
Assisted reproductive technology - IVF treatment in Ireland: A study of couples with successful outcomes27.302
Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review27.302
Fertility preservation for age-related fertility decline27.302
Methods employed to overcome difficult embryo transfer during assisted reproduction treatment27.302
Role of tubal surgery in the era of assisted reproductive technology: a committee opinion27.302
The clinical efficacy and efficiency of a 100-IU starting dose of recombinant follicle stimulating hormone (Puregon) in Korean women undergoing in vitro fertilization and embryo transfer27.302
Role of the mental health professional in education and support of the medical staff27.302
Subclinical hypothyroidism in the infertile female population: a guideline27.302
Fertility Preservation in Women with Ovarian Endometriosis27.302
Molecular aspects and clinical methods for preserving ovarian reserves in women receiving cancer treatment27.302
What women want? A scoping survey on women's knowledge, attitudes and behaviours towards ovarian reserve testing and egg freezing.27.302
Effect of advanced maternal age on maternal and neonatal outcomes in assisted reproductive technology pregnancies27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Long-acting follicle-stimulating hormone versus daily follicle-stimulating hormone for women undergoing assisted reproduction27.302
Urinary triclosan concentrations and diminished ovarian reserve among women undergoing treatment in a fertility clinic27.302
The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis27.302
Infertility in advanced reproductive age. Results of in vitro fertilization and embryo transfer according to the woman's age.27.302
Maternal Racial and Ethnic Disparities in Neonatal Birth Outcomes With and Without Assisted Reproduction27.302
Assessment of ovarian reserve and fertility preservation strategies in children treated for cancer.27.302
Increasing awareness of age-related fertility and elective fertility preservation among medical students and house staff: a pre- and post-intervention analysis27.302
Factors predicting double embryo implantation following double embryo transfer in assisted reproductive technology: implications for elective single embryo transfer27.302
EXPRESSION OF CONCERN: Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response27.302
Guidance on the limits to the number of embryos to transfer: a committee opinion27.302
Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology27.302
Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers27.302
The cutoff values of serum AMH levels and starting recFSH doses for the individualization of IVF treatment strategies27.302
Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey27.302
Omics in Reproductive Medicine: Application of Novel Technologies to Improve the IVF Success Rate27.302
Pregnancy After Modified Natural Cycle IVF: Case Report of a Young Patient With Elevated FSH Levels and Male Factor Infertility27.302
Performing the embryo transfer: a guideline27.302
Effect of smoking on ovarian reserve and ovarian stimulation in in- vitro fertilization and embryo transfer27.302
Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion27.302
Comparison of serum anti-mullerian hormone among fertile and infertile normal and diminished ovarian reserve groups27.302
Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria27.302
A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age.27.302
Assisted reproductive technology: public funding and the voluntary shift to single embryo transfer in Australia27.302
The fertility myth: Israeli students' knowledge regarding age-related fertility decline and late pregnancies in an era of assisted reproduction technology.27.302
Egg freezing for age-related fertility decline: preventive medicine or a further medicalization of reproduction? Analyzing the new Israeli policy27.302
Assisted reproductive techniques in Latin America: the Latin American Registry, 201327.302
Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report27.302
Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles27.302
Position statement on West Nile virus: a committee opinion27.302
Anti-Müllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years27.302
Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer27.302
Assessment of ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with familial Mediterranean fever27.302
Women's intentions to use fertility preservation to prevent age-related fertility decline27.302
Higher proportion of birth defects with assisted reproductive technology may not be attributable to advanced maternal age.27.302
Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome27.302
Recommendations for practices utilizing gestational carriers: a committee opinion27.302
Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction?27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus27.302
Fertility preservation and reproduction in cancer patients27.302
Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus27.302
Risk of ectopic pregnancy is linked to endometrial thickness in a retrospective cohort study of 8120 assisted reproduction technology cycles27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile Virus27.302
Cumulative number and morphological score of embryos resulting in success: realistic expectations from in vitro fertilization-embryo transfer27.302
Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study27.302
The relationship between the changes in the level of progesterone and the outcome ofin vitrofertilization-embryo transfer27.302
Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction27.302
Position on reproductive donors and smallpox vaccine: a committee opinion27.302
Hormonal and Clinical Predictors for Post-egg Retrieval Pain in Women Undergoing Assisted Reproductive Technology Procedures.27.302
Current differences and consequences of legislation on practice of assisted reproductive technology in the Nordic countries. The Nordic Committee on Assisted Reproduction of the Scandinavian Federation of Societies of Obstetrics and Gynecology27.302
Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization–Embryo Transfer Outcomes27.302
Safety in reproductive medicine: breadth, depth and discovery27.302
Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies27.302
Advanced maternal age: ethical and medical considerations for assisted reproductive technology27.302
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials27.302
Testing and interpreting measures of ovarian reserve: a committee opinion27.302
The Russian experience of autotransplantation of vitrified ovarian tissue to a cancer patient27.302
Mature oocyte cryopreservation: a guideline27.302
Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows27.302
Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology27.302
Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion27.302
Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion27.302
Guidelines for development of an emergency plan for in vitro fertilization programs27.302
Tiaogeng Yijing decoction improves the pregnancy outcomes of patients with poor ovarian response undergoing in vitro fertilization-embryo transfer27.302
Fertility Treatments in the United States: Improving Access and Outcomes27.302
Viability of cumulus cells is associated with basal AMH levels in assisted reproduction.27.302
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression27.302
Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction27.302
Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients.27.302
Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women27.302
Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment27.302
IVF Treatment and Single Embryo Transfer27.302
Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy27.302
Clinical Utility of Measurement of Anti-Müllerian Hormone in Reproductive Endocrinology27.302
Do ovarian reserve tests predict miscarriage in women undergoing assisted reproduction treatment?27.302
Effects of electroacupuncture on in vitro fertilization-embryo transfer (IVF-ET) of patients with poor ovarian response27.302
Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction27.302
Repetitive oocyte donation: a committee opinion27.302
Cystic fibrosis (cf) and ovarian reserve: A cross-sectional study examining serum anti-mullerian hormone (amh) in young women27.302
Triple marker screening for fetal chromosomal abnormalities in Korean women of advanced maternal age.27.302
Optimizing natural fertility: a committee opinion27.302
Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong.27.302
Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist27.302
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion27.302
Estimation of the Contribution of Assisted and Non-Assisted Reproductive Technology Fertility Treatments to Multiple Births During the Past 30 Years in Japan: 1979–200827.302
Perinatal outcomes after assisted reproductive technology treatment in Australia and New Zealand: single versus double embryo transfer.27.302
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve27.302
Examining the relationship between ovarian reserve, as measured by basal FSH levels, and the risk of poor obstetric outcome in singleton IVF gestations27.302
The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment27.302
Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer27.302
Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience27.302
Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study.27.302
Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer27.302
Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine27.302
Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel’s commentary ‘Evidenced-based medicine and the role of the National Health Service in assisted reproduction’27.302
Risk-sharing or refund programs in assisted reproduction: a committee opinion27.302
Reproductive medicine and the law: egg donation in Germany, Spain and other European countries27.302
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial27.302
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment27.302
Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level27.302
Anti-mullerian hormone as a marker of ovarian reserve27.302
Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment27.302
Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial27.302
First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient27.302
The association between poor ovarian response and thrombophilia in assisted reproduction27.302
Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates27.302
Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation27.302
Anti-Mullerian hormone (AMH): what do we still need to know?27.302
The Impact of Adnexal Torsion on Antral Follicle Count when Compared With Contralateral Ovary27.302
Guidelines on number of embryos transferred27.302
Blastocyst culture is associated with an elevated incidence of monozygotic twinning after single embryo transfer27.302
Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer27.302
Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology?27.302
Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure27.302
Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin27.302
Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Repo27.302
The three-dimensional ultrasonographic ovarian vascularity of women developing poor ovarian response during assisted reproduction treatment and its predictive value27.302
Trends and factors associated with the Day 5 embryo transfer, assisted reproductive technology surveillance, USA, 2001-2009.27.302
Antral follicle count at down-regulation and prediction of poor ovarian response27.302
Does very advanced maternal age, with or without egg donation, really increase obstetric risk in a large tertiary center?27.302
Infertile women of advanced reproductive age. Variability of day 3 FSH and E2 levels.27.302
Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey27.302
Embryo transfer practices in the United States: a survey of clinics registered with the Society for Assisted Reproductive Technology27.302
Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners27.302
Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria.27.302
Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program27.302
Factors associated with dizygotic twinning after IVF treatment with double embryo transfer27.302
Treatment period and medical care costs to achieve the first live birth by assisted reproductive technology are lower in the single embryo transfer period than in the double embryo transfer period: a retrospective analysis of women younger than 40 y27.302
Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome27.302
No increase in autism-associated genetic events in children conceived by assisted reproduction27.302
Three successful pregnancies with in vitro fertilization embryo transfer over an eight year time span despite elevated basal serum follicle stimulating hormone levels. Case report27.302
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion27.302
Age-related nomograms for antral follicle count and anti-Mullerian hormone for subfertile Chinese women in Singapore27.302
Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society for Assisted Reproductive Technology27.302
Medical egg freezing: the importance of a patient-centered approach to fertility preservation27.302
Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death27.302
Stimulation of endometrium embryo transfer can improve implantation and pregnancy rates for patients undergoing assisted reproductive technology for the first time with a high-grade blastocyst27.302
Congenital Malformations in Singleton Infants Conceived by Assisted Reproductive Technologies and Singleton Infants by Natural Conception in Tehran, Iran27.302
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients27.302
Egg Freezing for Age-Related Fertility Decline27.302
The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model27.302
Effects of transcutaneous electrical acupoint stimulation on ovarian reserve of patients with diminished ovarian reserve in in vitro fertilization and embryo transfer cycles27.302
The Importance of the Periconception Period: Immediate Effects in Cattle Breeding and in Assisted Reproduction Such as Artificial Insemination and Embryo Transfer27.302
Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion27.302
Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion27.302
Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion27.302
Mitochondrial SIRT5 is present in follicular cells and is altered by reduced ovarian reserve and advanced maternal age27.302
Correlation of serum anti-Mullerian hormone to follicular follicle stimulating hormone and implantation potential of the ensuing embryos27.302
The impact of the new Turkish regulation, imposing single embryo transfer after assisted reproduction technology, on neonatal intensive care unit utilization: a single center experience.27.302
Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization27.302
Donor Motivations, Associated Risks and Ethical Considerations of Oocyte Donation27.302
Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry27.302
Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Poor knowledge of age-related fertility decline and assisted reproduction among healthcare professionals27.302
A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors27.302
Assisted reproductive technology in reproductive medicine - possibilities and limitations27.302
Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India27.302
The impact of unilateral oophorectomy on ovarian reserve in assisted reproduction: a systematic review and meta-analysis27.302
Assessment of ovarian reserve by antral follicle count in ovaries with endometrioma27.302
Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?27.302
Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures.27.302
Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology outcomes between 2004 and 2013.27.302
Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study27.302
Effect of follicular flushing on reproductive outcomes in patients with poor ovarian response undergoing assisted reproductive technology27.302
Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort27.302
Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment27.302
There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy27.302
The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF.27.302
American Society for Reproductive Medicine Updates Consent Forms for Egg Donation27.302
Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer27.302
Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response27.302
BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles27.302
Uncommon but devastating event: total fertilisation failure following intracytoplasmic sperm injection27.302
Does ovarian reserve predict egg quality in unstimulated therapeutic donor insemination cycles?27.302
The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome27.302
Live birth in a 50-year-old woman following in vitro fertilization–embryo transfer with autologous oocytes: a rare case report27.302
Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET27.302
Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion27.302
Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology27.302
Mitochondrial SIRT3 and its target glutamate dehydrogenase are altered in follicular cells of women with reduced ovarian reserve or advanced maternal age27.302
The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology27.302
Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis27.302
What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics?27.302
Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count27.302
A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count.27.302
Recommendations for gamete and embryo donation: a committee opinion27.302
Testing and interpreting measures of ovarian reserve: a committee opinion27.302
Colour Doppler assessment of ascendent uterine artery perfusion in an in-vitro fertilization-embryo transfer programme after pituitary desensitization and ovarian stimulation with human recombinant follicle stimulating hormone27.302
Women with reduced ovarian reserve or advanced maternal age have an altered follicular environment27.302
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve27.302
The effect of laparoscopic ovarian cystectomy versus coagulation in bilateral endometriomas on ovarian reserve as determined by antral follicle count and ovarian volume: a prospective randomized study27.302
Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients27.302
Evaluation of compliance and range of fees among American Society for Reproductive Medicine-listed egg donor and surrogacy agencies27.302
2008 Guidelines for gamete and embryo donation: a Practice Committee report27.302
Round spermatid nucleus injection (ROSNI).27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion27.302
Improved pregnancy outcome for women with decreased ovarian oocyte reserve and advanced reproductive age by performing in vitro fertilization-embryo transfer27.302
Guidelines for development of an emergency plan for in vitro fertilization programs27.302
Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment?27.302
Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation27.302
Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births27.302
Prognosis following in vitro fertilization-embryo transfer (IVF-ET) in patients with elevated day 2 or 3 serum follicle stimulating hormone (FSH) is better in younger vs older patients27.302
Follicle stimulating hormone measured in unextracted urine throughout the menstrual cycle correlates with age and ovarian reserve27.302
Assisted reproduction technique outcomes for fresh versus deferred cryopreserved day-2 embryo transfer: a retrospective matched cohort study27.302
Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme27.302
Ethical issues of egg donation27.302
Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model27.302
Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles27.302
Controversies in assisted reproduction: oocyte donation. Protocols for egg donation27.302
Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer27.302
Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women27.302
Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.27.302
Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction?27.302
Assisted reproductive technology : strategies of elective single embryo transfer27.302
Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients27.302
The significance of blastocyst culture for discarded embryos in the treatment period of in-vitro fertilization and embryo transfer without available embryos27.302
CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer27.302
Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study27.302
Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers27.302
1995 assisted reproductive technology success rates: national summary and fertility clinic report.27.302
2006 Guidelines for Gamete and Embryo Donation27.302
Elements to be considered in obtaining informed consent for ART.27.302
Advanced maternal age as an indication for preimplantation genetic diagnosis (PGD)--the need for more judicious application in clinically assisted reproduction27.302
Efficiency of changing the embryo transfer time from day 3 to day 2 among women with poor ovarian response: a prospective randomized trial27.302
Rethinking the biological clock: eleventh-hour moms, miracle moms and meanings of age-related infertility27.302
Cetrorelix in women with poor ovarian response in previous assisted reproduction cycles27.302
Use of fetal oocytes in assisted reproduction27.302
Optimizing natural fertility: a committee opinion27.302
Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.27.302
Expectations for success in fertility treatment involving assisted reproduction27.302
Reproductive medicine in transition: new developments in embryo transfer27.302
Different perspectives of patients and health care professionals on the potential benefits and risks of blastocyst culture and multiple embryo transfer27.302
Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs.27.302
Annual report of Reproductive Endocrinology Committee, Japan Society of Obstetrics and Gynecology, 201327.302
Evaluation of Ovarian Reserve Based on Hormonal Parameters, Ovarian Volume, and Antral Follicle Count in Women with Type 2 Diabetes Mellitus27.302
Revised guidelines for human embryology and andrology laboratories27.302
Age, oestradiol and blastocysts can predict success in natural cycle IVF-embryo transfer27.302
With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization27.302
High basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction27.302
Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An ana27.302
Becoming a mother by non-anonymous egg donation: secrecy and the relationship between egg recipient, egg donor and egg donation child27.302
AIDA for reproductive medicine and the fertility clinic27.302
The interval transfer of a frozen-thawed embryo is more successful than a fresh embryo transfer for women undergoing IVF with recurrent implantation failure after cleavage stage embryo biopsy27.302
Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old?27.302
Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer27.302
Economic implications of the Society for Assisted Reproductive Technology embryo transfer guidelines: healthcare dollars saved by reducing iatrogenic triplets27.302
Successful pregnancy following a single fresh embryo transfer in a 45-year-old woman whose early follicular phase serum follicle stimulating hormone was 29 mIU/ml27.302
Estrous cycle staging before mating led to increased efficiency in the production of pseudopregnant recipients without negatively affecting embryo transfer in mice27.302
AIUM practice guideline for ultrasonography in reproductive medicine27.302
Surveillance of congenital malformations in infants conceived through assisted reproductive technology or other fertility treatments27.302
Ovarian reserve evaluation by anti-mullerian hormone in women undergoing laparoscopic cystectomy of endometrioma27.302
Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle27.302
Effect of follicle stimulating hormone on the secretion of anti-mullerian hormone in the granulosa cells in patients with polycystic ovarian syndrome27.302
Recommendations for practices utilizing gestational carriers: a committee opinion27.302
Trust women to choose: a response to John a Robertson's 'Egg freezing and Egg banking: empowerment and alienation in assisted reproduction'.27.302
Recombinant-follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment27.302
Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial27.302
Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE†27.302
A combination of follicle stimulating hormone, estradiol and age is associated with the pregnancy outcome for women undergoing assisted reproduction: a retrospective cohort analysis27.302
Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline27.302
Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type27.302
Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion27.302
Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation27.302
In-vitro fertilization (IVF), embryo transfer (ET) and assisted reproduction in the State of Israel27.302
Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer27.302
Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence?27.302
Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference27.302
Egg Quality and Pregnancy Outcome in Young Infertile Women with Diminished Ovarian Reserve27.302
Position statement on West Nile virus: a committee opinion27.302
Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage27.302
Egg donation model: an excellent way to isolate and analyze the impact of the male partner on assisted reproductive technology outcome27.302
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)27.302
Misconduct in third-party assisted reproduction: an Ethics Committee opinion27.302
Re: Fertility Preservation for Men with Testicular Cancer: Is Sperm Cryopreservation Cost Effective in the Era of Assisted Reproductive Technology?27.302
Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion27.302
Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion27.302
Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion27.302
Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee27.302
Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine27.302
DHEA use to improve likelihood of IVF/ICSI success in patients with diminished ovarian reserve: A systematic review and meta-analysis27.302
The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa27.302
Fertility preservation for age-related fertility decline27.302
Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents27.302
Large for gestational age and macrosomia in singletons born after frozen/thawed embryo transfer (FET) in assisted reproductive technology (ART)27.302
Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved27.302
Single Human Embryo Transfer in Assisted Reproduction Programs27.302
Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)27.302
Trigger Time in Advanced Maternal Age Patients With Low AMH27.302
Health in Childhood Following Assisted Reproductive Technology27.302
Clinical Cohort Study on the Endocrinology and Vaginal Microbiome of the Luteal Phase in Assisted Reproduction27.302
The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates27.302
Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)27.302
Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial27.302
Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Liga27.302
Does the Embryo Transfer Technique Affect the Success of in Vitro Fertilization?27.302
Aneuploidy Rate and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH27.302
Clinical Measures of Ovarian Reserve in Predicting IVF Success27.302
Abstracts for 2017 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference27.302
What advice should we give our patients to preserve their fertility and avoid needing oocyte donation in the future? - A Social Fertility Preservation program27.302
Safety data for the use of nasal human menopausal gonadotropins: a potential novel approach for fertility treatment27.302
Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics27.302
Correlation between Ovarian Reserve and Incidence of Ectopic Pregnancy after Fertilization and Embryo Transfer27.302
Efficacy of Hypnosis During Embryo Transfer Procedure on Clinical Pregnancy Rate for Patients Undergoing Assisted Reproductive Technology IVF or ICSI27.302
Delayed Embryo Transfer in Poor Responders27.302
Biomarkers of Ovarian Reserve and Correlation With IVF Treatments27.302
Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.27.302
A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment27.302
Electro-acupuncture and Assisted Reproductive Technology27.302
Bed Rest or no Bed Rest?27.302
Egg Freezing Pilot Study27.302
Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age27.302
EmbryoGlue as an Embryo Transfer Medium27.302
The Accuracy of Endometrial Ultrasound to Predict Implantation27.302
Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer27.302
Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates27.302
Comparison of Oocyte Maturation Trigger Using Follicle Stimulating Hormone Plus Human Chorionic Gonadotropin versus hCG Alone in Assisted Reproduction Technology Cycles27.302
Blastocyst Euploidy Assessment and Conditioned embryO traNsfer27.302
Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism27.302
Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve27.302
Effect of Follicular Phase Acupuncture on Anti-Mullerian Hormone in Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF And The Effect on Assisted Reproduction Outcome27.302
Embryo Kinetics and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH27.302
A Study to Evaluate the Baseline Follicle Stimulating Hormone, Ovarian Volume and Antral Follicle Count as Prognostic Factors of the Outcome of In-vitro Fertilisation/Intracytosolic Sperm Injection in Infertile Patients Receiving Gonal f for Con27.302
Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles27.302
Antimullerian Hormone in Endometriomas27.302
Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count27.302
Acupuncture for Treatment of Patients With Poor Ovarian Response27.302
Newborns From Patients Treated With ART (Assisted Reproductive Technology)27.302
Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment27.302
Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound27.302
Blastocyst Culture Using Time-lapse in Good Prognosis IVF Patients and Elective Single Embryo Transfer27.302
Evaluating the AMH Levels During Natural Cycle27.302
Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET27.302
Study Comparing Outcomes Between Conventional IVF and a "Freeze-all"-Strategy in Assisted Reproductive Technology27.302
Antimullerian Hormone Versus Antral Follicle Count for Determination of Gonadotrophin Dosing in IVF27.302
In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology (SART), The American Fertility Society27.302
In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1989 results from the IVF-ET Registry. Medical Research International, Society for Assisted Reproductive Technology, The American Fertility Society27.302
In vitro fertilization-embryo transfer in the United States: 1988 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology. American Fertility Society27.302
Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer27.302
In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings27.302
The functional ovarian reserve in assisted reproduction. A clinical dilemma27.302
Evaluating ovarian reserve: follicle stimulating hormone and oestradiol variability during cycle days 2-527.302
Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Methodology of human embryo transfer following assisted reproduction27.302
Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization27.302
Reproductive medicine and assisted reproduction--present status and perspectives in the Czech Republic27.302
Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Blastocyst culture and transfer in a assisted reproduction programme27.302
The genetic sonogram: its use in the detection of chromosomal abnormalities in fetuses of women of advanced maternal age27.302
A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice opinion. American Society for Reproductive Immunology Antiphospholipid27.302
Long GnRH-agonist protocol in an IVF program. Is it appropriate for women with normal FSH levels and high FSH/LH ratios?27.302
Gonadotropin and body mass index: high FSH levels in lean, normally cycling women27.302
Round spermatid nucleus injection (ROSNI)27.302
Embryo transfer: a critical step in assisted reproduction27.302
Assisted Reproductive Technology in the United States and Canada: 1995 Results Generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
First established pregnancy and birth after induction of ovulation with recombinant human follicle stimulating hormone during in vitro fertilization-embryo transfer and intracytoplasmic sperm injection27.302
The Impact of Lifestyle on Sperm Telomere Length and Telomerase Activity in Men Undergoing IVF Treatments27.302
Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion27.302
Ovarian tissue and oocyte cryopreservation27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Preimplantation genetic diagnosis27.302
Guidelines on number of embryos transferred27.302
Revised guidelines for human embryology and andrology laboratories27.302
Access to fertility treatment by gays, lesbians, and unmarried persons27.302
[Towards a single embryo transfer: predictive value of uterine and embryological parameters in assisted reproduction outcome]27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
Elective single embryo transfer in assisted reproduction27.302
Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer27.302
FSH levels in the menopausal or castrated women afflicted with breast cancer in an advanced phase. Influence of adrenal interventions27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Removal of cervical mucus prior to embryo transfer improves pregnancy rates in women undergoing assisted reproduction27.302
Health economic consequences of the choice of follicle stimulating hormone alternatives in IVF treatment27.302
Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States27.302
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation27.302
Ovarian Reserve and Ankylosing Spondylitis27.302
Guidelines for advertising by ART programs27.302
Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid27.302
Guidelines on the number of embryos transferred27.302
Guidelines for advertising by ART programs27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Round spermatid nucleus injection (ROSNI)27.302
Blastocyst production and transfer in clinical assisted reproduction27.302
Shared-risk or refund programs in assisted reproduction27.302
Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples27.302
Fertility treatment when the prognosis is very poor or futile27.302
Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment?27.302
Assisted reproductive technology has been detrimental to academic reproductive endocrinology and infertility27.302
Assisted reproductive technology has been detrimental to academic reproductive endocrinology and infertility: depth of the problem and possible solutions27.302
Elective single embryo transfer versus double embryo transfer in assisted reproduction27.302
Single embryo transfer in IVF treatment27.302
Age-related fertility decline: a committee opinion27.302
Effect of embryo transfer number on singleton and twin implantation pregnancy outcomes after assisted reproductive technology27.302
Response by the leadership of the Society of Assisted Reproductive Technology (SART) to the article “Assisted Reproduction and Choices in the Biotech Age”27.302
Age-related fertility decline: a committee opinion27.302
Guidelines for reducing the risk of viral transmission during fertility treatment27.302
Anti-phospholipid antibodies do not affect IVF success27.302
Genetic considerations related to intracytoplasmic sperm injection (ICSI)27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Ovarian tissue and oocyte cryopreservation27.302
Revised guidelines for human embryology and andrology laboratories27.302
Acupuncture intervention combined with assisted reproductive technology: its different effects at different time points during the in vitro fertilization-embryo transfer course27.302
Antral follicle count in clinical practice: building the bridge from ovarian reserve to in vitro fertilization outcome27.302
Effect of the new legislation and single-embryo transfer policy in Turkey on assisted reproduction outcomes: preliminary results27.302
Changing attitudes towards non-invasive aneuploidy screening at advanced maternal age in a German tertiary care center27.302
A skewed sex ratio following blastocyst culture is a consequence of embryo grading systems that prioritise male embryos for transfer27.302
Committee opinion: role of tubal surgery in the era of assisted reproductive technology27.302
A persistent misperception: assisted reproductive technology can reverse the “aged biological clock”27.302
Practice patterns and outcomes with the use of single embryo transfer in the United States27.302
Incorporation of a follicle stimulating hormone used for embryo transfer in cattle into multilamellar liposomes27.302
Recommendations for practices utilizing gestational carriers: an ASRM Practice Committee guideline27.302
Fertility treatment when the prognosis is very poor or futile: a committee opinion27.302
Results after assisted reproduction at a public fertility clinic27.302
Reproductive endocrinology: vitamin D and AMH levels are correlated in human adults27.302
Position statement on West Nile virus: a committee opinion27.302
Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Guidelines on number of embryos transferred27.302
Effect of different embryo transfer strategies on the outcome of assisted reproduction27.302
Re: "Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births"27.302
Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti‐Müllerian hormone and small antral follicle count using three‐dimensional ultrasound27.302
Criteria for number of embryos to transfer: a committee opinion27.302
Uterine contractile activity at Embryo Transfer – as a new pharmacotherapeutic target in assisted reproduction27.302
Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan27.302
AIUM Practice Guideline for the Performance of a Focused Reproductive Endocrinology and Infertility Scan27.302
Reply: Endometrioma excision and ovarian reserve: do assessments by antral follicle count and anti-Müllerian hormone yield contradictory results?27.302
Endometrioma excision and ovarian reserve; do assessments by antral follicle count and anti-Müllerian hormone yield contradictory results?27.302
Ovarian reserve and anti-Mullerian hormone (AMH) in mothers of dizygotic twins27.302
Effects of Intraovarian Platelet Rich Plasma in Women With Poor Ovarian Response and Premature Ovarian Insufficiency27.302
Comparing the Effect of Laparoscopic Supracervical and Total Hysterectomy for Uterine Fibroids on Ovarian Reserve by Assessing Serum Anti-Mullerian Hormone Levels: A Prospective Cohort Study27.302
The effect of isotretinoin on ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with acne27.302
Fertility preservation for age-related fertility decline – Authors' reply27.302
Fertility preservation for age-related fertility decline27.302
Psychosocial factors in reproductive medicine27.302
Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages27.302
Surgery Before Embryo Transfer in ERROR (Endometrioma Related Reduction in Ovarian Reserve)27.302
Use of reproductive technology for sex selection for nonmedical reasons27.302
Processing of semen by density gradient centrifugation selects spermatozoa with longer telomeres for assisted reproduction techniques27.302
[Assisted Reproductive Technology in Female Transplant Recipients: Experience of a Reproductive Medicine Unit and Literature Review]27.302
Successful pregnancy following assisted reproduction and transmyometrial embryo transfer in a patient with anatomical distortion of the cervical canal27.302
Validity for assisted hatching on pregnancy rate in assisted reproductive technology: Analysis based on results of Japan Assisted Reproductive Technology Registry System 201027.302
Should all embryos be cultured to blastocyst for advanced maternal age women with low ovarian reserve: a single center retrospective study27.302
The combination of dehydroepiandrosterone, transdermal testosterone, and growth hormone as an adjuvant therapy in assisted reproductive technology cycles in patients aged below 40 years with diminished ovarian reserve27.302
Evaluation of ovarian reserve using anti-müllerian hormone and antral follicle count in Sjögren's syndrome: Preliminary study27.302
[Influence of assisted reproductive technology and related factors on chromosomal abnormalities in early spontaneous abortions]27.302
Preimplantation genetic testing in assisted reproductive technology27.302
ASRM standard embryo transfer protocol template: a committee opinion27.302
The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study27.302
Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes27.302
Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion27.302
A systematic review on concurrent aneuploidy screening and preimplantation genetic testing for hereditary disorders: What is the prevalence of aneuploidy and is there a clinical effect from aneuploidy screening?27.302
Elective egg freezing for age-related fertility decline27.302
Reporting assisted reproductive technology success rates on Australian and New Zealand fertility clinic websites27.302
An Economic Analysis of Aneuploidy Screening of Oocytes in Assisted Reproduction in Germany27.302
Minimum standards for practices offering assisted reproductive technologies: a committee opinion27.302
Preimplantation genetic testing in assisted reproduction technology27.302
Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study27.302
Assisted Reproductive Technology and the Reproductive Endocrinology and Infertility Specialist in the U.S. Military27.302
Women's attitudes and beliefs about using fertility preservation to prevent age-related fertility decline-A two-year follow-up27.302
Serum anti-Mullerian hormone (AMH) concentration has limited prognostic value for density of primordial and primary follicles, questioning it as an accurate parameter for the ovarian reserve27.302
Eleven healthy live births: a result of simultaneous preimplantation genetic testing of α- and β-double thalassemia and aneuploidy screening27.302
Re: Assisted Reproductive Technology Outcomes in Female-to-Male Transgender Patients Compared with Cisgender Patients: A New Frontier in Reproductive Medicine27.302
Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial27.302
Herbal fertility treatments used in North America from colonial times to 1900, and their potential for improving the success rate of assisted reproductive technology27.302
Outcomes of in vitro fertilization-embryo transfer in women with diminished ovarian reserve after growth hormone pretreatment27.302
Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic27.302
Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure27.302
Androgenicity and fertility treatment in women with unexplained infertility27.302
Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine27.302
Assessment of Turkey IVF (In Vitro Fertilization) websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines27.302
The effect of acupuncture on anti-mullerian hormone and assisted reproduction outcome in Polycystic Ovary Syndrome patients undergoing in vitro fertilization27.302
Preimplantation Genetic Testing of Aneuploidy by Next Generation Sequencing: Association of Maternal Age and Chromosomal Abnormalities of Blastocyst27.302
Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women27.302
Second-generation preimplantation genetic testing for aneuploidy in assisted reproduction: a SWOT analysis27.302
Application of embryo biopsy and sex determination via polymerase chain reaction in a commercial equine embryo transfer program in Argentina27.302
Preimplantation Genetic Testing for Aneuploidy Improves Clinical, Gestational, and Neonatal Outcomes in Advanced Maternal Age Patients Without Compromising Cumulative Live-Birth Rate27.302
Abstracts presented at the 2019 Foundation for Reproductive Medicine Conference on Translational Reproductive Biology and Clinical Reproductive Endocrinology27.302
Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve27.302
The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic27.302
The Effect of Assisted Hatching on Live Birth Rate Following Fresh Embryo Transfer in Advanced Maternal Age27.302
[Medically Assisted Reproduction in Natural Cycle: Outcome Evaluation of a Reproductive Medicine Department]27.302
Severity of Diminished Ovarian Reserve and Chance of Success with Assisted Reproductive Technology27.302
Corticosteroids Prior to Embryo Transfer in Assisted Reproduction in Women with Crohn's Disease and Ulcerative Colitis - A Nationwide Cohort Study27.302
[Exploration of the process of prenatal screening and diagnosis for women with advanced maternal age based on results of 351 cases of fetal chromosomal abnormalities]27.302
A counterintuitive lesson in family planning? Patience first: taking a "gap year" after live birth from assisted reproductive technology before frozen embryo transfer is performed27.302
The impact of the localisation of endometriosis lesions on ovarian reserve and assisted reproduction techniques outcomes27.302
Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH)27.302
[Prediction of clinical outcomes of patients with surplus cleavage-stage embryos for blastocyst culture after D3 embryo transfer]27.302
Does preimplantation genetic testing for aneuploidy really improve IVF outcomes in advanced maternal age patients without compromising cumulative live-birth rate?27.302
Zygotic splitting following embryo biopsy: a cohort study of 207 697 single-embryo transfers following IVF treatment27.302
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion27.302
EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists27.302
Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer27.302
Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply27.302
A novel mathematical model of true ovarian reserve assessment based on predicted probability of poor ovarian response: a retrospective cohort study27.302
Reproductive success of assisted reproductive technology in couples with chromosomal abnormalities27.302
Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer27.302
Transfer of embryos with positive results following preimplantation genetic testing for monogenic disorders (PGT-M): experience of two high-volume fertility clinics27.302
Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion27.302
A Chinese practice guideline of the assisted reproductive technology strategies for women with advanced age27.302
Re: Egg Donation Model: An Excellent Way to Isolate and Analyze the Impact of the Male Partner on Assisted Reproductive Technology Outcome27.302
Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve27.302
Exposure to Fine Particulate Matter and Ovarian Reserve Among Women from a Fertility Clinic27.302
Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome27.302
Elective egg freezing and male support: a qualitative study of men's roles in women's fertility preservation27.302
An economic analysis of preimplantation genetic testing for aneuploidy by polar body biopsy in advanced maternal age27.302
Performance of preimplantation genetic testing for aneuploidy in IVF cycles for patients with advanced maternal age, repeat implantation failure, and idiopathic recurrent miscarriage27.302
A novel de novo partial xq duplication in a girl with short stature, nonverbal learning disability and diminished ovarian reserve - effect of growth hormone treatment and fertility preservation strategies: a case report and up-to-date review27.302
Role of aneuploidy screening in preimplantation genetic testing for monogenic diseases in young women27.302
Prognostic role of preimplantation genetic testing for aneuploidy in medically indicated fertility preservation27.302
Embryo transfer associated with hormone replacement therapy cycles using assisted reproductive technology increases placenta accreta spectrum27.302
Evaluation of the effect of the elective blastocyst-stage embryo transfer and freezing strategy on the abandonment of frozen embryos under the Taiwan National Assisted Reproduction Act27.302